Table 4.
Five-year relative survival of all patients by age group and SEER stage between 2006–2010 and 2011–2015
| SEER stage | Year | ≤39 yr |
40-49 yr |
50-59 yr |
60-69 yr |
≥70 yr |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No. | % (95% CI) | No. | % (95% CI) | No. | % (95% CI) | No. | % (95% CI) | No. | % (95% CI) | ||
| Overall | 2006-2010 | 3,161 | 73.6 (72.1-75.2) | 10,471 | 77.4 (76.6-78.2) | 23,113 | 79.9 (79.4-80.5) | 30,885 | 77.6 (77.0-78.1) | 33,949 | 60.8 (60.1-61.4) |
| 2011-2015 | 2,848 | 75.6 (73.5-77.5) | 10,037 | 79.4 (78.3-80.3) | 27,474 | 82.1 (81.5-82.7) | 32,533 | 81.2 (80.6-81.8) | 46,567 | 64.8 (64.1-65.5) | |
| Local | 2006-2010 | 877 | 95. 9(94.3-97.1) | 3,349 | 97.4 (96.7-98.0) | 8,334 | 97.4 (96.9-97.9) | 10,957 | 96.3 (95.6-96.9) | 10,217 | 82.7 (81.6-83.9) |
| 2011-2015 | 804 | 96.8 (94.6-98.2) | 3,370 | 97.1 (96.2-97.9) | 10,729 | 97.9 (97.4-98.4) | 12,767 | 97.6 (96.9-98.2) | 14,472 | 88.6 (87.4-89.8) | |
| Regional | 2006-2010 | 1,384 | 80.4 (78.2-82.4) | 4,446 | 84.2 (83.0-85.2) | 9,510 | 84.3 (83.5-85.1) | 12,730 | 81.7 (80.9-82.5) | 13,548 | 69.8 (68.7-70.8) |
| 2011-2015 | 1,341 | 85.6 (82.8-88.0) | 4,416 | 86.8 (85.3-88.1) | 11,639 | 87.2 (86.3-88.1) | 13,838 | 85.9 (84.9-86.7) | 20,667 | 73.8 (72.6-74.9) | |
| Distant | 2006-1010 | 626 | 24.2 (20.9-27.7) | 1,801 | 24.5 (22.5-26.6) | 3,356 | 24.7 (23.2-26.2) | 4,362 | 21.9 (20.6-23.2) | 5,412 | 12.5 (11.5-13.5) |
| 2011-2015 | 592 | 21.1 (16.7-25.9) | 1,884 | 28.0 (25.2-30.8) | 4,102 | 25.8 (23.9-27.7) | 4,633 | 23.0 (21.3-24.6) | 7,732 | 11.8 (10.7-12.9) | |
| Unknown | 2006-2010 | 274 | 81.1 (75.9-85.3) | 875 | 75.6 (72.5-78.4) | 1,913 | 78.9 (76.9-80.8) | 2,836 | 72.4 (70.5-74.2) | 4,772 | 42.4 (40.7-44.1) |
| 2011-2015 | 111 | 79.1 (68.3-86.6) | 367 | 82.1 (76.8-86.4) | 1,004 | 79.2 (75.9-82.1) | 1,295 | 75.8 (72.7-78.7) | 3,696 | 33.6 (31.3-35.9) | |
SEER, Surveillance, Epidemiology, and End Results; CI, confidence interval.